semaglutide tablet form ODT Pills Rybelsus (semaglutide): Uses, Side Effects,

Preliminary observational study

GLP-1 receptor agonists, including semaglutide and tirzepatide, have revolutionized the approach to weight loss

After a 4-week run-in period in which participants were treated with diet and exercise alone, those who fulfilled the randomisation criteria were randomised (1:1:1:1) using a web-based randomisation system to receive once-daily oral semaglutide 3 mg, 7 mg or 14 mg or placebo for 26 weeks (using a 4-week dose-escalation regimen for the higher doses)

A study of adults with diabetes suggests patients with obstructive sleep apnea derive a 20% greater mortality reduction from GLP-1 therapy than those without the sleep disorder.

Considerations for employers who are thinking about covering GLP-1 drugs for weight loss.